Melanoma-Specific Clinical Outcomes of Inpatient Immune Checkpoint Blockade Treatment.
Kimberly LooHannah L KalvinKatherine S PanageasVivian ParkMichael A PostowPublished in: The oncologist (2022)
Despite overall poor outcomes, some patients may benefit from inpatient ICB. This study provides additional information for clinicians to appropriately counsel patients on expectations following inpatient ICB.